	Diagnostic and Prognostic Values of Bile Biomarkers for Malignant Biliary Stenosis. Liver Int Gigante E, Untereiner V, Caruso S, Rhaiem R, Grados L, Boulagnon-Rombi C, Adam S, Sockalingum GD, Garnotel R, Thiefin G. PMID: 42015571 [PubMed - indexed for MEDLINE]
	Nutritional-Inflammatory Recovery After Metal versus Plastic Biliary Stenting in Elderly Cholangiocarcinoma: A Prospective Observational Cohort Study. Clin Interv Aging Li C, Zhang N, Ren H. PMID: 42005307 [PubMed - indexed for MEDLINE]
	IgG4-sclerosing cholangitis masquerading as cholangiocarcinoma: a case report of an unresolved preoperative diagnosis. Front Immunol Liu YA, Gao X, Gao W, Hu Z, Wang F, Qu Y, Zheng Y. PMID: 42004961 [PubMed - indexed for MEDLINE]
	Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx). BMC Cancer Lagenfelt H, Blomstrand H, Gränsmark E, Elander NO. PMID: 41998525 [PubMed - indexed for MEDLINE]
	First-Line Chemotherapy Regimens for Unresectable Locally Advanced or Metastatic Biliary Tract Cancer: A Systematic Review and Bayesian Network Meta-Analysis. JAMA Netw Open Elemosho A, Blair AB, Angez M, Chatzipanagiotou OP, Mevawalla A, Alizai Q, Yuza K, Pawlik TM. PMID: 41984480 [PubMed - indexed for MEDLINE]
	Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience. JCO Precis Oncol Abidoye O, Pirozzi A, Okano N, Raupach EA, Elliott N, Guzman E, Urquieta B, Rone K, Andrews K, Wu C, Sonbol MB, Ahn D, Bekaii-Saab T, Borad MJ. PMID: 41955548 [PubMed - indexed for MEDLINE]
	Exosomes and cholangiocarcinoma: mechanisms, diagnostic, and therapeutic perspectives. Front Immunol Zhang J, Chen M. PMID: 41939857 [PubMed - indexed for MEDLINE]
	Case Report: Primary gallbladder undifferentiated small round cell sarcomas treated with gemcitabine, paclitaxel, bevacizumab and pembrolizumab achieved remarkable tumor regression. Front Immunol Liu D, Liu X, Li M, Li X. PMID: 41924256 [PubMed - indexed for MEDLINE]
	Clonorchis sinensis and cholangiocarcinoma: molecular mechanisms and biomarker advances. Parasite Huang C, Wu Y, Wu A, Huang L, Fang S, Xu C, Liu T, Li Y, Li X. PMID: 41919759 [PubMed - indexed for MEDLINE]
	Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Int J Mol Sci Deb Nath T, Mukherjee A, Chauhan SC, Bandyopadhyay D. PMID: 41898574 [PubMed - indexed for MEDLINE]
	Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer. Anticancer Res Oh CR, DO JH, Oh HC, Choi YS, Lee SE, Hong SA, Hong M, Hwang IG. PMID: 41895770 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High-Risk Recurrence Factors: A Phase II Single-Center Prospective Study. Cancer Med Tian Y, Lei T, Ruan Q, Zhou X, Shen R, Xie T, Li S, Cai X, Chen M. PMID: 41891390 [PubMed - indexed for MEDLINE]
	Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study. BJS Open Al-Saffar HA, Ten Haaft BHEA, Marino R, De Bellis M, Olthof PB, Busund S, Schultz NA, Gilg S, Ruzzenente A, Groot Koerkamp B, Erdmann JI, Ratti F, Yaqub S, Pommergaard HC, Sturesson C. PMID: 41871373 [PubMed - indexed for MEDLINE]
	The evolving role of futibatinib for advanced cholangiocarcinoma. Expert Rev Gastroenterol Hepatol Persano M, Casadei-Gardini A, Camera S, Rimini M. PMID: 41869869 [PubMed - indexed for MEDLINE]
	Case Report: Spontaneous Tumor Lysis Syndrome in a Patient With Cholangiocarcinoma. J Investig Med High Impact Case Rep Lasprilla-Pallares MA, Nakazaki JC, Rivera-Castro JA. PMID: 41867062 [PubMed - indexed for MEDLINE]
	Treatment Outcomes of Durvalumab Combination Therapy in Patients with Biliary Tract Cancer. Tokai J Exp Clin Med Ito H, Kojima S, Tazawa Y, Omura Y, Yamaguchi T, Cho T, Yoshihara S, Nagata J, Hirose S, Ogasawara T, Izumi H, Kaneko J, Suzuki T. PMID: 41859807 [PubMed - indexed for MEDLINE]
	Lipidomic analysis of bile from patients with extrahepatic cholangiocarcinoma. PLoS One Choi SJ, Kim HJ, Kwon SW, Kim WS, Kim JS. PMID: 41855188 [PubMed - indexed for MEDLINE]
	Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301. ESMO Open Abou-Alfa GK, Borbath I, Roychowdhury S, Goyal L, Lamarca A, Macarulla T, Shroff RT, Oh DY, Tama, Savastano DM, van Veenhuyzen DF, Xu C, Freas E, Solanas J, Javle MM. PMID: 41850040 [PubMed - indexed for MEDLINE]
	Prophylactic Closure of Mucosal Defect to Prevent Delayed Bleeding After Endoscopic Papillectomy. Can J Gastroenterol Hepatol Dong J, Teng G, Zhang L, Niu H, Bian D, Feng Q. PMID: 41846432 [PubMed - indexed for MEDLINE]
	Mri-based Ki-67 prediction for intrahepatic cholangiocarcinoma: Risk stratification and treatment efficacy prediction. Eur J Radiol Zheng B, Zhou L, Liu K, Han J, Wang B, Sheng R, Zeng M. PMID: 41846064 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 17261

Page 1 of 864



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy